Advocating for Change: Firefighter Ryan Gardill’s Testimony on Psilocybin as a Treatment for Mental Health Issues

Pennsylvania Lawmakers Hear Testimony on Psilocybin as a Mental Health Treatment

Harrisburg, PA — In a powerful testimony before state lawmakers on Tuesday, Manheim Township firefighter Ryan Gardill shared his harrowing journey from the battlefield in Afghanistan to the depths of despair, advocating for alternative treatments for mental health issues, particularly the use of psilocybin, a compound found in “magic mushrooms.”

Returning from military service in 2011, Gardill faced a series of personal crises, including a failed marriage and a child custody battle. By 2013, after two years of unsuccessful treatments for depression and post-traumatic stress disorder (PTSD), Gardill found himself in a dark place, contemplating suicide. It was his wife who intervened, helping him seek the support he desperately needed.

“I now take my experiences and what I went through to try and advocate to those around me that this is a serious issue,” Gardill told the House Democrats’ policy committee. “It’s a silent issue. It’s not talked about. There is a stigma, but we can get through the stigma and work our way through all of this.”

Gardill, who now works as a support coordinator at Pennsylvania’s firefighters association, emphasized the need for unconventional methods to tackle complex mental health challenges. He spoke in favor of bipartisan legislation introduced by state Reps. Jennifer O’Mara (D) and Craig Williams (R) to legalize psilocybin treatments in Pennsylvania, contingent upon FDA approval and rescheduling by the DEA.

O’Mara and Williams expressed optimism about the future of psilocybin, stating in a memo, “We see legal use of psilocybin on the horizon,” and that their proposal aims to ensure “timely access to groundbreaking new treatments.”

Research supports their claims; a 2022 study from Johns Hopkins Medicine indicated that microdoses of psilocybin could have lasting antidepressant effects for some patients. This is not the first time psilocybin has been considered by lawmakers. In 2022, Sen. Tracy Pennycuick (R) sought to establish clinical studies for psilocybin-assisted therapies, although the legislation stalled.

Brett Waters, a New York attorney and co-founder of the nonprofit Reason for Hope, also testified, sharing how psilocybin helped him overcome depression and anxiety after losing his mother to suicide in 2018. Waters criticized traditional antidepressants, stating, “We believe psilocybin will be safer, more effective, more durable and with lower abuse potential.”

The urgency for change in mental health treatment was underscored by the CDC’s alarming statistics, revealing nearly 50,000 suicide deaths in 2023 alone. State Rep. Mike Schlossberg (D-Lehigh), who has openly discussed his struggles with mental health, raised concerns about the stigma surrounding these issues, which could hinder bipartisan support for psilocybin use.

Both Gardill and Waters emphasized that mental health transcends party lines, calling for a collective effort to address the crisis. They were joined by other advocates, including medical professionals and representatives from biotechnology firms specializing in psilocybin treatments.

As the discussion continues, the potential for psilocybin to revolutionize mental health care remains a focal point for lawmakers and advocates alike, highlighting the urgent need for innovative solutions in the face of a growing mental health crisis.

For those in crisis, help is available. Call or text 988 for confidential support.